Myopericarditis after Covid-19 Vaccination – a Case Series

Authors :: Manan Pareek
Linda Casale
Erica S. Spatz
Robert Fishman
Jamieson O’Marr
Laura R. Glick
Yanting Wang
Ian Ferguson
Jeremy D. Asnes
Jeremy Steele
Daniel Jacoby
Rohan Khera
Damianos G Kokkinidis
Robert W. Elder
Adam E. Schussheim
Erin Faherty
Lauren A. Baldassarre
Kevin Hall
Jennifer M. Kwan
Edward Tuohy
Nihar R. Desai
Edward J. Miller
Zaniar Ghazizadeh
Source :: SSRN Electronic Journal.
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.
Abstract: Myopericarditis has been observed among individuals receiving the BNT162b2-mRNA and mRNA-1273 COVID-19 vaccines.1,2 In this case series, we describe the initial experience with myopericarditis following COVID-19 vaccination across the largest healthcare system in Connecticut.

Subjects :: Vaccination
Pediatrics
medicine.medical_specialty
Pericarditis
Myocarditis
Coronavirus disease 2019 (COVID-19)
Adverse drug event
business.industry
medicine
medicine.disease
business
Myopericarditis
Healthcare system

Full Text Access

Tools